Per- and Polyfluoroalkyl Substances in Early Pregnancy and Risk for Preeclampsia: A Case-Control Study in Southern Sweden.
PFAS
PFHxS
PFNA
PFOA
PFOS
Sweden
biobank
preeclampsia
register
Journal
Toxics
ISSN: 2305-6304
Titre abrégé: Toxics
Pays: Switzerland
ID NLM: 101639637
Informations de publication
Date de publication:
16 Jun 2020
16 Jun 2020
Historique:
received:
29
04
2020
revised:
05
06
2020
accepted:
09
06
2020
entrez:
21
6
2020
pubmed:
21
6
2020
medline:
21
6
2020
Statut:
epublish
Résumé
Preeclampsia is one of the most common causes of perinatal and maternal morbidity/mortality. One suggested environmental risk factor is exposure to endocrine-disrupting pollutants such as per- and polyfluoroalkyl substances (PFAS). The present case-control study in southern Sweden aims to investigate the hypothesized association between serum concentrations of PFAS in early pregnancy and the risk of developing preeclampsia. The study included 296 women diagnosed with preeclampsia (cases) and 580 healthy pregnant women (controls). Maternal serum samples were obtained from a biobank of samples collected in early pregnancy in connection with screening for infections. Serum concentrations of perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), perfluorononanoic acid (PFNA), and perfluorohexane sulfonate (PFHxS) were analyzed using liquid chromatography-tandem-mass-spectrometry (LC/MS/MS). Among primiparous women, there were no differences in PFAS concentrations in early pregnancy between the cases and the controls whereas among multipara women, the cases had significantly higher concentrations of PFNA (median concentrations were 0.44 and 0.38 ng/mL,
Identifiants
pubmed: 32560030
pii: toxics8020043
doi: 10.3390/toxics8020043
pmc: PMC7355444
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Am J Epidemiol. 2014 Apr 1;179(7):824-33
pubmed: 24557813
EFSA J. 2018 Dec 13;16(12):e05194
pubmed: 32625773
Front Physiol. 2015 Jan 13;5:516
pubmed: 25628568
Sci Rep. 2019 Jun 24;9(1):9179
pubmed: 31235847
Chemosphere. 2019 Sep;231:326-336
pubmed: 31132539
Semin Perinatol. 2009 Jun;33(3):130-7
pubmed: 19464502
Chemosphere. 2012 Sep;88(11):1269-75
pubmed: 22494529
Best Pract Res Clin Obstet Gynaecol. 2011 Jun;25(3):329-42
pubmed: 21349772
Epidemiology. 2012 May;23(3):386-92
pubmed: 22370857
Rev Environ Health. 2005 Jan-Mar;20(1):57-64
pubmed: 15835498
Am J Epidemiol. 2009 Oct 1;170(7):837-46
pubmed: 19692329
Acta Paediatr. 1996 Jul;85(7):843-8
pubmed: 8819552
Chemosphere. 2008 Nov;73(10):1617-24
pubmed: 18834614
Environ Health Perspect. 2017 Apr;125(4):502-510
pubmed: 27385067
Environ Health. 2019 Jan 9;18(1):5
pubmed: 30626391
Curr Hypertens Rep. 2018 Aug 8;20(10):87
pubmed: 30090982
Environ Health Perspect. 2013 Oct;121(10):1207-13
pubmed: 23838280
Environ Health Perspect. 2007 Sep;115(9):1298-305
pubmed: 17805419
Acta Obstet Gynecol Scand Suppl. 1997;164:37-9
pubmed: 9225634
Occup Environ Med. 2018 Jan;75(1):46-51
pubmed: 29133598
PLoS One. 2012;7(9):e44767
pubmed: 23028613